TAVR VS. SAVR IN PATIENTS WITH CANCER AND AORTIC STENOSIS: A NATIONWIDE READMISSION DATABASE REGISTRY STUDY

Patients with cancer and aortic stenosis (AS) represent a clinic challenge, especially when aortic valve replacement (AVR) is required. We sought to compare outcomes of transcatheter (TAVR) vs surgical (SAVR) AVR in patients with cancer. Based on the Nationwide Readmission Database, we identified